Comparison of supraclavicular brachiocephalic and femoral vein approaches for tunneled dialysis catheter placement in patients with thrombosed internal jugular veins
Hemodialysis International · 2024
DOI: 10.1111/hdi.13117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hemodialysis International, 2024. Verfasst von Umut Oguslu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Biruni University Faculty of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Catheterization, Central Venous, Thrombosis, Central Venous Catheters, Vascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Introduction
There is still debate on the best access route in case of bilateral internal jugular vein thrombosis. We aimed to compare the safety, effectiveness, and outcomes of tunneled dialysis catheter placement via supraclavicular brachiocephalic and femoral vein approaches in patients with bilateral internal jugular vein thrombosis.
Methods
Between January 2018 and December 2021, data of the patients in whom tunneled dialysis catheters were placed via the supraclavicular brachiocephalic vein ( n = 42) and femoral vein ( n = 57) approaches were extracted. Patient demographics, technical and clinical success rates, complications, and outcomes were noted. The Likert scale was used to assess patient satisfaction.
Findings
Forty two (42.4%) patients were men, and the mean age was 61.9 (range, 12–93) years. The technical and clinical success rate was 100% for both groups. No major complication was encountered. The mean follow‐up period was 497.5 (range, 32–1698) catheter days. Thirty‐day patency was similar for the brachiocephalic vein and femoral vein group (40 [95.2%] vs. 55 [96.5%], p = 0.754). Also, primary and cumulative patency rates were comparable ( p = 0.158; p = 0.660). The infection rate was 2.6 and 4.1 per 1000 catheter days for the brachiocephalic vein and femoral vein group. The infection‐free survival was significantly higher in the brachiocephalic vein group (71.9% vs. 35.3% at 12 months, p < 0.001). Patient satisfaction was higher in the brachiocephalic vein group (median satisfaction, 5 vs. 4, p < 0.001).
Discussion
Both supraclavicular brachiocephalic vein and femoral vein approaches have high technical and clinical success with comparable patency rates. However, low infection rate and high patient satisfaction make the supraclavicular brachiocephalic vein approach a reasonable alternative before proceeding to the femoral vein access.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Biruni University Faculty of Medicine, Istanbul, Turkey.
- Department of Radiology, Medicana Health Group, Istanbul, Turkey.
- Department of Cardiology, Medicana Health Group, Istanbul, Turkey.
- Department of Nephrology, Okan University Hospital, Istanbul, Turkey.
- Department of Radiology, Bahçelievler Public Hospital, Istanbul, Turkey.
ORCID-Profile: Umut Oguslu, Burçak Gümüş, Murat Yalçin, Osman Zikrullah Sahin, Gökalp Yilmaz
Zitieren
APA
Oguslu, U., Gümüş, B., Yalçin, M., Sahin, O. Z., & Yilmaz, G. (2024). Comparison of supraclavicular brachiocephalic and femoral vein approaches for tunneled dialysis catheter placement in patients with thrombosed internal jugular veins. Hemodialysis International. https://doi.org/10.1111/hdi.13117
Vancouver
Oguslu U, Gümüş B, Yalçin M, Sahin OZ, Yilmaz G. Comparison of supraclavicular brachiocephalic and femoral vein approaches for tunneled dialysis catheter placement in patients with thrombosed internal jugular veins. Hemodialysis International. 2024. doi:10.1111/hdi.13117
BibTeX
@article{Oguslu2024,
author = {Oguslu, Umut and Gümüş, Burçak and Yalçin, Murat and Sahin, Osman Zikrullah and Yilmaz, Gökalp},
title = {Comparison of supraclavicular brachiocephalic and femoral vein approaches for tunneled dialysis catheter placement in patients with thrombosed internal jugular veins},
journal = {Hemodialysis International},
year = {2024},
doi = {10.1111/hdi.13117}
}
EUVIMED